Brevan Howard Capital Management LP

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1512857 ST. HELIER, Y9

Position in VRTX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,753,376

+$7,345,882 QoQ

Shares Held

17,622

+459.1% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#385

of 1,705 holders

Holding Since

Sep 2023

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Brevan Howard Capital Management LP holds $183,834,510 across 129 Biotechnology names. VRTX ranks #4 (4.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ROIV	Roivant Sciences Ltd.	517,621	$18,318,607
2	MRNA	Moderna, Inc.	181,105	$12,682,782
3	BBIO	BridgeBio Pharma, Inc.	155,727	$11,598,546
4	VRTX	Vertex Pharmaceuticals Inc / Ma This page	17,622	$8,753,376
5	AXSM	Axsome Therapeutics, Inc.	31,928	$7,815,015
6	DFTX	Definium Therapeutics, Inc.	156,812	$7,376,435
7	SNDX	Syndax Pharmaceuticals Inc	309,065	$6,756,160
8	INCY	Incyte Corp	45,270	$5,131,807

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,753,376	17,622	+459.1%	Shares	Defined	2026-08-14
2026-03-31	$1,407,494	3,152	-56.6%	Shares	Defined	2026-05-15
2024-12-31	$2,927,628	7,270	-1.6%	Shares	Defined	2025-02-14
2024-09-30	$3,436,475	7,389	+67.0%	Shares	Defined	2024-11-14
2024-06-30	$2,073,617	4,424	-4.5%	Shares	Defined	2024-08-14
2024-03-31	$1,936,222	4,632	-4.1%	Shares	Defined	2024-05-15
2023-12-31	$1,965,278	4,830	+216.3%	Shares	Defined	2024-02-14
2023-09-30	$530,998	1,527	—	Shares	Defined	2023-11-14
No filing history on record for this holder in this stock.